`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`RIMFROST AS
`Petitioner,
`
`v.
`
`AKER BIOMARINE ANTARCTIC AS
`Patent Owner.
`
`
`
`
`Case IPR2020-01533
`
`U.S Patent No. 9,816,046
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER’S REQUEST FOR DIRECTOR REVIEW
`
`
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`TABLE OF CONTENTS
`TABLE OF AUTHORITIES .......................................................................... ii
`
`I.
`
`II.
`
`Statement of Relief Requested .............................................................. 1
`
`Summary of the Proceedings ................................................................. 2
`
`III. Argument ............................................................................................... 6
`
`IV. Conclusion ........................................................................................... 14
`
`CERTIFICATE OF SERVICE ......................................................................... i
`
`
`i
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`TABLE OF AUTHORITIES
`
`Cases
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`Eli Lilly, 902 F.2d 943, 945 (Fed. Cir. 1990)................................................................................ 12
`
`Henny Penny Corporation v. Frymaster LLC, 938 F.3d 1324, 1330 (Fed. Cir. 2019)................. 11
`
`Intelligent Bio-Sys., Inc. v. Illumina Cambridge Ltd., 821 F.3d 1359, 1369 (Fed. Cir. 2016) ....... 8
`
`Intelligent Bio-Sys., Inc., 821 F.3d 1359, 1367 (Fed. Cir. 2016) .................................................. 11
`
`Magnum Oil Tools Int’l, Ltd., 829 F.3d 1364, 1378 (Fed. Cir. 2016) .................................... 13, 14
`
`Nuvasive, Inc., 841 F.3d 966, 971 (Fed. Cir. 2016) ...................................................................... 13
`
`SAS Institute, Inc. v. Complementsoft, LLC, 825 F.3d 1341, 1351 (Fed. Cir. 2016) .............. 13, 14
`
`SAS Institute, Inc. v. Iancu, ––– U.S. ––––, 138 S.Ct. 1348, 200 L.Ed.2d 695 (2018) .................. 7
`
`Wasica Finance GmbH v. Continental Automotive Systems, Inc. 853 F.3d 1272, 1286-87 (Fed.
`Cir. 2017) .................................................................................................................................. 11
`
`Statutes
`
`35 U.S.C. §312(a)(3) ....................................................................................................... 7, 8, 11, 13
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ii
`
`
`
`Patent Owner Aker Biomarine Antarctic AS (“Aker”) requests review by the
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`
`
`Director of the Board’s finding in its Final Written Decision (Paper 33 (“FWD”))
`
`that claims 1-20 (collectively, the “challenged claims”) of U.S. Patent No.
`
`9,816,046 (the “ ’046 patent”) are unpatentable. (FWD, 39-40).
`
`I.
`
`Statement of Relief Requested
`
`In the FWD, the Board held the challenged claims were unpatentable as
`
`obvious, concluding: claims 1-10 were unpatentable over Breivik II, Yoshitomi,
`
`Budziński, Fricke, Bottino II and Sampalis I (Ground 1); claims 11-12 were
`
`unpatentable over Breivik II, Yoshitomi, Budziński, Fricke, Bottino II and
`
`Randolph (Ground 2); and claims 13-19 were unpatentable over Breivik II,
`
`Yoshitomi, Budziński, Fricke, Bottino II, Randolph and Sampalis I (Ground 3).
`
`FWD, 39. However, as stated by the Board in Footnote 15: “As noted above, we
`
`have considered Petitioner's grounds without relying on Breivik II.” FWD, 39.
`
`Thus, the Board actually found the claims obvious over sub-combinations (i.e.,
`
`combinations not including Breivik II) of the combinations of references identified
`
`in the Petition and Instituted Grounds. In doing so, the Board specifically avoided
`
`addressing Aker’s evidence that Breivik II is not prior art due to earlier invention.
`
`Aker respectfully submits that the Board erred by basing its decision on
`
`Grounds not including Breivik II, when all three of the Instituted Grounds
`
`specifically combined and relied on Breivik II. As a result, Aker contends that
`
`
`
`1
`
`
`
`
`Petitioner did not meets its burden of establishing obviousness because Breivik II
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`is not prior art, rendering all of the Instituted Grounds insufficient.
`
`Aker respectfully requests that the FWD be vacated with respect to
`
`unpatentability of the challenged claims and the case remanded to the Board for a
`
`determination of whether Breivik II is prior art and decision on whether the
`
`challenged claims are patentable over the actual requested and Instituted Grounds
`
`that include Breivik II as the lead reference.
`
`II.
`
`Summary of the Proceedings
`
`The ‘046 Patent contains claims to methods of extracting krill oil with
`
`specific properties from a krill meal that has been stored from 1 to 36 months.
`
`FWD, 6.
`
`The Petition (Paper 2, “Pet.”) provided the following chart in a section
`
`entitled “Specific Statutory Grounds on which the Challenge is Based (37 C.F.R. §
`
`42.104(b)(2)).” Pet., 11.
`
`
`
`2
`
`
`
`
`
`
`In Section VII of the Petition, Petitioner stated: “A discussion of Grounds 1-3 for
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`claim invalidation is detailed below.” Pet., 40. Petitioner then presented Grounds
`
`1-3 under the following headings:
`
` Ground 1: § 103(a) – Breivik II, Yoshitomi, Budziński, Fricke, Bottino II,
`
`Sampalis 1 [Claims 1-10] (Emphasis added) Pet., 41;
`
` Ground 2: § 103(a) – Breivik II, Yoshitomi, Budziński, Fricke, Bottino II,
`
`and Randolph [Claims 11-12] (Emphasis added) Pet., 57;
`
` Ground 3: § 103(a) – Breivik II, Yoshitomi, Budziński, Fricke, Bottino II,
`
`Randolph and Sampalis I [Claims 13-19] (Emphasis added) Pet., 60.
`
`In its discussion of Claim 1 under Ground 1, Petitioner concluded:
`
`“Accordingly, the method of producing krill oil as recited in claim 1 would have
`
`been obvious in view of Breivik II, Yoshitomi, Budziński, Fricke and Bottino II.”
`
`(Emphasis added) Pet., 46. In its discussion of independent Claim 13 under Ground
`
`3, Petitioner concluded: “Based on the foregoing, the method of producing krill oil
`
`as recited in claim 13 would have been obvious in view of Breivik II, Yoshitomi,
`
`Budziński, Fricke, Bottino II and Randolph.” (Emphasis added) Pet., 64.
`
`With respect to motivation to combine under Ground 1, Petitioner
`
`concluded:
`
`Accordingly, a POSITA would have possessed reasons and motivation to
`combine the processing, storage and extraction steps disclosed in Breivik
`II, Yoshitomi Budziński and Fricke, and would have been motivated to look
`
`
`
`3
`
`
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`
`
`to references such as Bottino II to ascertain the other components present in
`krill oil extracts and their respective amounts, and would have administered
`krill oil extracts in an encapsulated dosage form as described in Sampalis I.
`
`(Emphasis added) Pet. 56-57.
`
`With respect to motivation to combine under Ground 3, Petitioner stated:
`
`A POSITA would have possessed reasons and the motivation to combine
`the teachings of Breivik II, Yoshitomi, Budziński, Fricke, Bottino II,
`Randolph and Sampalis I, and would have had a reasonable expectation of
`producing krill oil as recited in claims 13-19.
`
`(Emphasis added) Pet. 66.
`
`
`
`The Board instituted the Inter Partes Review. (Institution Decision, Paper 6,
`
`“ID”). In the ID, the Board reproduced the table from the Petition including the
`
`Instituted Grounds in a section entitled “Challenged Claims and Asserted
`
`Grounds” :
`
`
`
`ID, 6. With regard to Ground 1, the Board stated: “Petitioner contends that the
`
`subject matter of claims 1–10 would have been obvious over the combined
`
`disclosures of Breivik II, Yoshitomi, Budziński, Fricke, Bottino II, and Sampalis
`
`I.” (Emphasis added) ID, 8. With regard to Ground 2, the Board stated: “Petitioner
`
`
`
`4
`
`
`
`
`contends the subject matter of claims 11 and 12 would have been obvious over the
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`combined disclosures of Breivik II, Yoshitomi, Budziński, Fricke, Bottino II, and
`
`Randolph.” (Emphasis added) ID, 13. With regard to Ground 3, the Board
`
`specifically referred to the combined disclosures of “Breivik II, Yoshitomi,
`
`Budziński, Fricke, Bottino II, Randolph, and Sampalis I.” (Emphasis added) ID,
`
`18.
`
`
`
`Relying on the clear statements in the ID that the three Instituted Grounds
`
`were directed to combinations requiring Breivik II as the lead reference with the
`
`other listed references, Aker responded, in part, by presenting evidence of
`
`antedation of Breivik II by the inventors. (Patent Owner Response, Paper 9, “PO
`
`Resp.,” 17-38). Specifically, Aker argued that Breivik II was not prior art and that
`
`“[s]ince Ground 1 relies on Breivik II as the lead reference both for specific claim
`
`elements as well as motivation to combine the references, Ground 1 must be
`
`denied. As further discussed below, Grounds 2 and 3, which also rely on Breivik
`
`II, should be denied as well.”
`
`
`
`Petitioner filed a Reply. (Paper 14, “Reply”). In contrast to the Reply filed in
`
`IPR2020-1532, Petitioner did not argue that antedation of Breivik II was
`
`immaterial because one or more alternative references were provided for every
`
`limitation that Breivik II is cited for. Cf. IPR2020-01532 Paper 14, 7 and
`
`IPR2020-1533 Paper 14, 7. In fact, in the discussion of obviousness in its Reply,
`
`
`
`5
`
`
`
`
`Petitioner never once indicated that the combined references in each Ground do not
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`include Breivik II and instead cited to Breivik II multiple times. See Reply, 18-30.
`
`
`
`The Board ultimately found the claims obvious over a sub-combination of
`
`references not including Breivik II. FWD, 38-39. In so doing, the Board did not
`
`reach the issue of whether Breivik II was antedated by Aker’s evidence of earlier
`
`invention. FWD, 11. As stated by the Board:
`
`For the reasons set forth below, we determine that Petitioner has shown by a
`preponderance of the evidence that challenged claims 1-19 would have been
`obvious over Yoshitomi, Budziński, Fricke, Bottino II, and Sampalis I
`and/or Randolph, when considered in light of the undisputed knowledge of
`one of ordinary skill in the art. Thus, we need not decide whether Patent
`Owner's evidence of conception and reduction to practice is sufficient to
`antedate Breivik II with respect to these claims, as we do not rely on it as a
`prior art reference in this proceeding.
`
`FWD, 11. The Board provided no other explanation as to why it ignored the fact
`
`that the Grounds as set forth in the Petition as well as Instituted Grounds all
`
`combined Breivik II with the other listed references and did not present Breivik II
`
`as an alternative lead reference.
`
`III. Argument
`
`Aker respectfully submits that the Board committed error by finding the
`
`claims unpatentable over a combination of references that was different from the
`
`Grounds stated in the Petition and Institution Decision. The Board
`
`misapprehended that binding precedent precludes the Board from adopting in a
`
`
`
`6
`
`
`
`
`Final Written Decision obviousness theories not proposed by Petitioner. Indeed,
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`there is clear legal error in view of 35 U.S.C. §312(a)(3), the Administration
`
`Procedure Act, Federal Circuit precedent, and the PTAB’s Trial Practice Guide.
`
`The Board’s holding that it could rely on a sub-combination of references (not
`
`including Breivik II) rather than the actual Instituted Grounds (all of which
`
`included Breivik II) is not supported in the FWD by reference to any statute or
`
`precedent for inter partes review proceedings. As explained below, the Board’s
`
`actions directly contradict 35 U.S.C. §312(a)(3). If Aker had been provided notice
`
`that specific sub-combinations in this IPR, it could have used its limited pages and
`
`its expert to specifically address why those sub-combinations fail. Further, it would
`
`not be possible for Aker to address all possible sub-combinations. A holding that
`
`all possible sub-combinations of an Instituted Ground are in play in an instituted
`
`IPR would likely lead to gaming by future petitioners.
`
`The Supreme Court has explained that “in establishing inter partes review,
`
`Congress set forth “a process in which it’s the petitioner, not the Director, who
`
`gets to define the contours of the proceeding.” SAS Institute, Inc. v. Iancu, –––
`
`U.S. ––––, 138 S.Ct. 1348, 200 L.Ed.2d 695 (2018). The Court held that if the
`
`Director institutes review proceedings, the Board’s review must proceed “in
`
`accordance with or in conformance to the petition,” (Id. at 1356) including “ ‘each
`
`
`
`7
`
`
`
`
`claim challenged’ and ‘the grounds on which the challenge to each claim is based.’
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`” Id. at 1355 (quoting 35 U.S.C. §312(a)(3)).
`
`The Court stated: “Nothing suggests the Director enjoys a license to depart
`
`from the petition and institute a different inter partes review of his own design.”
`
`Id. at 1356 (emphasis in original). Thus the Court emphasized that “the petitioner’s
`
`petition, not the Director’s discretion, is supposed to guide the life of the
`
`litigation,” and that “the petitioner’s contentions, not the Director’s discretion,
`
`define the scope of the litigation all the way from institution through to
`
`conclusion.” Id. at 1356-57. Indeed, the petitioner is the “master of its
`
`complaint.” Id. at 1355.
`
`As further explained by the Federal Circuit: “[i]t is of the utmost importance
`
`that petitioners in the IPR proceedings adhere to the requirement that the initial
`
`petition identify ‘with particularity’ the ‘evidence that supports the grounds for the
`
`challenge to each claim.’ ” Intelligent Bio-Sys., Inc. v. Illumina Cambridge Ltd.,
`
`821 F.3d 1359, 1369 (Fed. Cir. 2016) (internally quoting 35 U.S.C. § 312(a)(3)).
`
`Aker respectfully submits that in the instant case the Board has departed
`
`from the Petition (and ID) and rendered a decision on a combination of references
`
`that was not one of the Grounds on which inter partes review was requested or
`
`instituted. As highlighted above, the Petition presented three grounds, each of
`
`which listed Breivik II as the lead reference. As further discussed above, in both
`
`
`
`8
`
`
`
`
`the statement of the statutory grounds (Pet., 10-11) and discussion of the three
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`grounds (Pet., 40-68), Petitioner consistently used the conjunction “and” when
`
`referring to the combination of references in all three Grounds as well as when
`
`arguing motivation to combine and reasonable expectation of success. Petitioner
`
`did use the conjunction “or” in its claim charts with respect to what references the
`
`claim elements are allegedly found in, but there is no indication in the claim charts
`
`that Petitioner intended to rely on a sub-combination of the six references
`
`specifically cited in Grounds 1 and 2 and the seven references cited in Ground 3,
`
`all three of which required Breivik II as the lead reference.
`
`When deciding to institute, the Board appeared to take Petitioner at its word
`
`that the Grounds advanced in the Petition included Breivik II, stating:
`
` “Petitioner contends that the subject matter of claims 1–10 would have been
`obvious over the combined disclosures of Breivik II, Yoshitomi, Budziński,
`Fricke, Bottino II, and Sampalis I.” (Emphasis added) ID, 8.
` “Petitioner contends the subject matter of claims 11 and 12 would have been
`obvious over the combined disclosures of Breivik II, Yoshitomi, Budziński,
`Fricke, Bottino II, and Randolph.” (Emphasis added) ID, 13.
` “Petitioner demonstrates a reasonable likelihood that the subject matter of
`claims 14–19 would have been obvious over the combined disclosures of
`Breivik II, Yoshitomi, Budziński, Fricke, Bottino II, Randolph, and
`Sampalis I.” (Emphasis added) ID, 18.
`
`
`However, instead of rendering a decision based on the Grounds requested by
`
`Petitioner and instituted in the ID, the Board held the claims unpatentable over
`
`sub-combinations of references that did not include Breivik II. For example, the
`
`
`
`9
`
`
`
`
`FWD restates Instituted Ground 1 as follows: “Petitioner contends that the subject
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`matter of claims 1-10 would have been obvious over the combined disclosures of
`
`Yoshitomi, Budziński, Fricke, Bottino II, and Sampalis I.” FWD, 12. By deleting
`
`Breivik II from the Instituted Grounds, the Board introduced a new theory of
`
`obviousness that did not rely on Breivik II. This was done for Grounds 2 and 3 as
`
`well. As another example, neither the Petition nor the ID explained why a person
`
`of ordinary skill in the art would specifically start with and modify either
`
`Yoshitomi, Fricke or Budziński (in the absence of Breivik II) in view of Bottino II
`
`and Randolph to arrive at the claimed invention. As another example, Petitioner
`
`did not present the Statutory Statement of Grounds in the Petition for Ground 1 as
`
`Breivik II or Budziński or Fricke or Yoshitomi in combination with Bottino II or
`
`Sampalis and instead chose to define the grounds as Breivik II, Yoshitomi,
`
`Budziński, Fricke, Bottino II and Sampalis I. See Pet., 46, 56-57.
`
`Since Petitioner is the “master of its complaint” as described by the Supreme
`
`Court in SAS, it could have presented Grounds that did not specifically rely on
`
`Breivik II or have phrased its Grounds in a way that provided notice that it was
`
`relying or intending to rely on the references in the alternative. The Grounds listed
`
`in the Petition and instituted by the Board failed to do this.
`
`The Federal Circuit has held that “shifting arguments” to a new theory of
`
`obviousness absent from the petition “is foreclosed by statute, our precedent, and
`
`
`
`10
`
`
`
`
`Board guidelines.” Wasica Finance GmbH v. Continental Automotive Systems, Inc.
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`853 F.3d 1272, 1286-87 (Fed. Cir. 2017)(citing 35 U.S.C. §312(a)(3) as requiring
`
`petitions to identify “with particularity . . . the grounds on which the challenge to
`
`each claim is based.”). Aker respectfully submits that by removing Breivik II from
`
`the Instituted Grounds (and the statement of Statutory Grounds requested in the
`
`Petition), the Board introduced a new theory of obviousness in contravention of the
`
`statutes and precedent discussed above. This is clear error.
`
`Additionally, the Federal Circuit has held: “Because of the expedited nature
`
`of IPR proceedings, ‘[i]t is of the utmost importance that petitioners in the IPR
`
`proceedings adhere to the requirement that the initial petition identify ‘with
`
`particularity’ the ‘evidence that supports the grounds for the challenge to each
`
`claim.’ ” Henny Penny Corporation v. Frymaster LLC, 938 F.3d 1324, 1330 (Fed.
`
`Cir. 2019)(citing Intelligent Bio-Sys., Inc., 821 F.3d 1359, 1367 (Fed. Cir. 2016).
`
`Thus, it was reasonable that Aker relied on the statements in the Petition and ID
`
`that identified the Instituted Grounds as including Breivik II. Indeed, if the Board
`
`can depart from the Instituted Grounds as stated in the Institution Decision, then all
`
`possible sub-combinations of references could be applied - numbering 720
`
`separate possible combinations of 6 references at the low end in Grounds 1 and 2
`
`and 5040 possible combinations of 7 references at the low end in Ground 3.
`
`
`
`11
`
`
`
`Because the proceeding is expedited, Aker could not reasonably be expected
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`
`
`to address all of the possible sub-combinations of references when the Petition and
`
`Instituted Grounds listed in the ID did not include or refer those sub-combinations.
`
`Instead, Aker relied on the Instituted Grounds as stated and used its limited time
`
`and pages in its Response to remove Breivik II as a reference. Moreover, because
`
`the Board pivoted from the Instituted Grounds to a different theory of obviousness
`
`based on the sub-combinations of references not including Breivik II, Aker had no
`
`opportunity to present expert testimony that addressed the specific sub-
`
`combinations of references and make specific arguments as to why the sub-
`
`combinations failed. It is well-established case law that once a prima facie case of
`
`obviousness is established and evidence is submitted in rebuttal, all evidence must
`
`be considered anew. In re Eli Lilly, 902 F.2d 943, 945 (Fed. Cir. 1990). The
`
`expedited nature of IPR proceedings does not allow the decision maker (or
`
`petitioner) to start over at some time after the institution decision. See, e.g., 2019
`
`Consolidated Trail Practice Guide, 74 (prohibiting parties from submitting
`
`evidence for a prima facie showing of obviousness in a reply).
`
`Holding that the Board may rely on a sub-combination of multiple cited
`
`references when the Petition and ID unambiguously indicate that the Grounds
`
`include all of the cited references would invite petitioners to state statutory
`
`grounds as including a list of “possible” references, wait for the patent owner’s
`
`
`
`12
`
`
`
`
`response, and then devise a sub-combination of references in reply to the
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`petitioner’s argument. This scenario is in contravention of 35 U.S.C. §312(a)(3)
`
`and should not be the policy of the Board. This is especially true where, as in this
`
`case, the Petitioner made no indication in its Reply that it was relying on a
`
`combination of references not including Breivik II. See Reply, 18-30.
`
`Finally, the Board’s adoption of an unpatentability theory not asserted by
`
`Petitioner violates the Administrative Procedure Act (“APA”). Under the APA an
`
`“agency must ‘timely inform[ ]’ the patent owner of ‘the matters of fact and law
`
`asserted,’” as well as provide patent owner with an opportunity to respond after
`
`notice is provided. In re Nuvasive, Inc., 841 F.3d 966, 971 (Fed. Cir. 2016)
`
`(quoting 5 U.S.C. § 554). This notice requirement of the APA is, in part, intended
`
`to prevent a party or the PTAB from “chang[ing] theories in midstream.” SAS
`
`Institute, Inc. v. Complementsoft, LLC, 825 F.3d 1341, 1351 (Fed. Cir. 2016). This
`
`notice requirement precludes the PTAB from allowing or asserting new theories to
`
`which a patent owner has no opportunity to respond. In re Magnum Oil Tools Int’l,
`
`Ltd., 829 F.3d 1364, 1378 (Fed. Cir. 2016).
`
`
`
`The Board’s reliance for the first time, in the FWD, on the sub-combinations
`
`of Yoshitomi, Budziński, Fricke, Bottino II, and Sampalis I (new Ground 1),
`
`Yoshitomi, Budziński, Fricke, Bottino II, and Randolph (new Ground 2), and
`
`Yoshitomi, Budziński, Fricke, Bottino II, Randolph, and Sampalis I (new Ground
`
`
`
`13
`
`
`
`
`3) to replace the Instituted Grounds that all included Breivik II violates the APA.
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`SAS, 825 F.3d at 1351-52 (vacating-in-part decision where the Board “change[d]
`
`theories in midstream” and applied a claim interpretation neither party advanced);
`
`Magnum Oil, 829 F.3d at 1380-81 (“[W]e find no support for the PTO’s position
`
`that the Board is free to adopt arguments on behalf of petitioners that could have
`
`been, but were not, raised by the petitioner during an IPR.”). It is respectfully
`
`submitted that the Board improperly amended the theory presented by Petitioner.
`
`
`
`In summary, Aker respectfully submits that the evidence of record
`
`demonstrates that the Board made clear errors in the FWD. The Board found the
`
`claims unpatentable over a sub-combination of references not including Breivik II,
`
`when the Petition and Institution Decision unambiguously stated that the Grounds
`
`included Breivik II.
`
`IV. Conclusion
`
`
`
`For the foregoing reasons, Aker respectfully requests that the FWD be
`
`vacated with respect to claims 1-19 of the ’046 patent and remanded to the Board
`
`for a determination of whether Breivik II is prior art and decision on whether the
`
`challenged claims are patentable over the Instituted Grounds that necessarily
`
`include Breivik II.
`
`
`
`
`
`
`
`14
`
`
`
`
`Dated: May 5, 2022 Respectfully submitted,
`
`
`
`
`
`
`
`
`
` /David A. Casimir /
`
`Reg. No. 42,395
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`
`
`
`
`
`
`15
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that on this 5th day of May 2022, a copy of
`
`IPR2020-01533
`U.S. Patent No. 9,816,046
`
`the foregoing Patent Owner’s Request for Director Review was served in its
`
`entirety electronically (as consented to by Petitioner) to the attorneys of record as
`
`follows:
`
`
`James F. Harrington
`
`Reg. No. 44,741
`
`Hoffmann & Baron, LLP
`jfhdocket@hbiplaw.com
`
`
`
`Ronald J. Baron
`
`
`Reg. No. 29,281
`Hoffman & Baron, LLP
`rjbdocket@hbiplaw.com
`
`046ipr@hbiplaw.com
`
`
`
`
`
`
`
`
`
`
`
`Michael I. Chakansky
`Reg. No. 31,600
`Hoffman & Baron, LLP
`micdocket@hbiplaw.com
`
`John T. Gallagher
`Reg. No. 35,516
`Hoffman & Baron, LLP
`jtgdocket@hbiplaw.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`By: /David A. Casimir/
`David A. Casimir, Ph.D.
`Registration No. 42,395
`Counsel for Patent Owner
`CASIMIR JONES, S.C.
`2275 Deming Way
`Suite 310
`Middleton, Wisconsin 53562
`(608) 662-1277
`
`i
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`